top of page
  • Writer's pictureanwilner

New Hope for ALS

Updated: Aug 15, 2021

Please join me in this interview with Sabrina Paganoni, MD, Ph.D., who presented clinical trial results at the American Academy of Neurology 2021 Virtual Annual Meeting that promise new hope for patients with amyotrophic lateral sclerosis (ALS). A new drug, AMX0035, demonstrated functional improvement and survival benefit, according to Dr. Paganoni. Any hope for patients with this devastating disease is welcome!

Here's the 10-minute interview:

For more fascinating interviews, please check out "The Art of Medicine with Dr. Andrew Wilner" on YouTube:

and your favorite podcast player.

Feedback is always appreciated!

Thanks for watching!

13 views0 comments

Recent Posts

See All

What about Toxic Tau?

Many thanks to Dr. George Bloom for a very informative interview about his research on toxic tau proteins in Alzheimer's disease. In this 10-minute interview, Dr. George Bloom, Professor of Biology, C

bottom of page